|
⚲
|
| Keyboard |
| Propel Bio Management LLC
✚
|
|
|---|---|
| CRD # | 322858 |
| SEC # | 801-126889 |
| CIK # | 0001969764 |
| AUM | 247.5 M (2026-03-23) |
| Employees | 7 (86% Investors, 0% Brokers) |
| Phone | 206-602-9246 |
| Address | 11620 Wilshire Blvd Los Angeles, CA 90025 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($M) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Plains GP Holdings LP | 30.2 | ||
| Oncogenex Pharmaceuticals Inc | 11.4 | ||
| Phathom Pharmaceuticals Inc | 9.4 | ||
| Delcath Systems Inc | 9.2 | ||
| Corcept Therapeutics Inc | 6.0 | ||
| Access Pharmaceuticals Inc | 6.0 | ||
| Vor Biopharma Inc | 5.6 | ||
| Kyverna Therapeutics Inc | 5.6 | ||
| Milestone Pharmaceuticals Inc | 5.1 | ||
| Celldex Therapeutics Inc | 4.1 | ||
| View All | |||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Propel Bio-Host Partners LP | 2025-12-02 | 99.3 M | |
| Other | Propel Bio SPV 3 LLC | 2025-03-25 | 19.3 M | |
| Other | PB SPV-1 LLC | 2024-07-09 | 2.5 M | |
| Other | Propel Bio SPV 2 LLC | [2024-03-25] | 8.8 M | 9.2 M |
| Offered $8,800,000 · Filed 2024-03-12 (D) · Exemption 506(b), 3(c), 3(c)(1) · Duration One year or less · Net Assets Decline to Disclose | ||||
| VC | Propel Bio Partners LP | [2022-10-17] | 39.0 M | 44.5 M |
| Offered $150,000,000 · Filed 2023-03-15 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Remaining $111,050,000 · Duration More than one year · Revenue Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 1 | 75.3 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 4 | 172.2 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 5 | 247.5 |
| By Discretionary | ||
| Discretionary | 5 | 247.5 |
| Non-Discretionary | 0 | 0.0 |
| Total | 5 | 247.5 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 247.5 | |
| Total | 5 | 247.5 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Leen Kawas | Director | 5 | 2 | |
| Propel Bio Management | Director | 2 | 2 | |
| A Delaware Limited Liability Company Pbp Partners LLC | Director | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001969764] | |
| SC 13D | [0001969764] | |
| SC 13G | [0001969764] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $0.0B |
| Serves | Institutional |
| Fund Types | Hedge Fund |
| Comparable Firms | State | AUM |
|---|---|---|
|
Coinshares Asset Management US LLC
✚
|
NY | 251.9 M |
|
Karlov Street Capital LLC
✚
|
FL | 251.0 M |
|
AC Investment Management LLC
✚
|
NY | 251.0 M |
|
Farley Capital LP
✚
|
250.3 M | |
|
Rivonia Road Capital LLC
✚
|
CA | 246.0 M |
|
3B Capital Management LP
✚
|
TX | 245.9 M |
|
Metronome Capital LLP
✚
|
244.9 M | |
|
Kultura Capital Management LP
✚
|
UT | 244.7 M |
|
Bandera Partners LLC
✚
|
NY | 244.1 M |
|
ShoreVest Partners Ltd
✚
|
244.0 M |